Dr. Reddy's gets FDA nod for Xeglyze


Patients 6 months of age and older with head lice infestation will soon have a new topical treatment.

The Food and Drug Administration has cleared Dr. Reddy’s Xeglyze (abametapir) lotion, 0.74%

The company is working to commercialize this product through partners. 

This ad will auto-close in 10 seconds